A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age
Clinical trial NCT01079949 · TERMINATED
Trial details
- NCT number
- NCT01079949
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2010-10-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.